Trials / Unknown
UnknownNCT00180947
Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse
Phase II Study of Vinorelbine + Cyclofosfamide Association Among Patients Reached of Refractory Tumours or in Relapse
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 210 (planned)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 12 Months – 25 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase II study to determine the antitumor activity of Vinorelbine and Cyclofosfamide association among patients with refractory tumours or in relapse with rhabdomyosarcomas and other soft tissue tumours, Ewing tumours, osteosarcomas, neuroblastomas or medulloblastomas.
Conditions
- Rhabdomyosarcomas
- Neoplasms, Connective and Soft Tissue
- Ewing Tumor
- Osteosarcomas
- Neuroblastomas
- Medulloblastomas
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vinorelbine, cyclofosfamide |
Timeline
- Start date
- 2003-06-01
- First posted
- 2005-09-16
- Last updated
- 2006-09-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00180947. Inclusion in this directory is not an endorsement.